DG

Divya Gaurav

Active Director Director DIN 07362448
DIN 07362448 First appointment May 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Divya Gaurav

Data last updated:

Divya Gaurav is a Director at Drsh Pharma Private Limited (since 2016). The company operates in Chemicals. Drsh Pharma Private Limited reported revenue of ₹1.3 Lakh (FY 2024).

DIN 07362448
Primary Designation Director
Industry Chemicals
First Appointment 25 May 2016
Oldest Company Age 10 yrs
Largest company Drsh Pharma Private Limited · ₹1.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drsh Pharma Private Limited U74999DL2016PTC300373
Director25 May 20162016₹1.3 Lakh (FY 2024)Active

Board colleagues of Divya Gaurav

NameDINCompanyDesignation
Rajesh Kumar07358360Drsh Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drsh Pharma Private Limited
Premium access

Shareholding and investment profile for Divya Gaurav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divya Gaurav

Divya Gaurav currently holds 1 directorship: Drsh Pharma Private Limited (Director, since 25 May 2016, revenue ₹1.3 Lakh (FY 2024)).

Divya Gaurav was first appointed on 25 May 2016 as Director at Drsh Pharma Private Limited.

The current boards of Divya Gaurav's companies include Rajesh Kumar (Drsh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available